MedReleaf Australia's subsidiary across the ditch has been granted a Medicinal Cannabis Supply Licence from the New Zealand Ministry of Health.The licence will enable MedReleaf NZ to acquire starting material, cannabis-based ingredients and medical cannabis products, including the import of such products into New Zealand. The company has also...

A study looking at medical marijuana legalization in the USA and its impact on opioid-related and pain-related outcomes revealed some interesting results.The cross-sectional study looked at records of tens of thousands of patients newly diagnosed with either breast, colorectal or lung cancer who were receiving anticancer treatment and lived...

Results of a survey relating to the use of Epidiolex (cannabidiol) oral solution in patients with Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS) indicates improvement in patient outcomes.Dravet and Lennox-Gastaut syndromes are rare conditions appearing during the first year of life, characterised by frequent fever-related seizures. These seizures tend...

A recently released report from the United Nations Conference On Trade And Development provides an interesting snapshot of the industrial hemp industry.Released last week, the "Commodities At A Glance: Special issue on industrial hemp" looks at the various uses of the crop, production and trade statistics, and how developing...

New Zealand medical cannabis company Helius Therapeutics has been awarded Good Agricultural and Collection Practice (GACP) certification for its facility in East Tamaki, Auckland.GACP guidelines were developed by the World Health Organization (WHO) nearly twenty years ago as part of an effort to improve the quality of medicinal plants/herbal...

As of last Thursday, medical marijuana patients in Rhode Island reportedly no longer need to pay for a medical cannabis card. But they will still pay tax on purchases.Patients no longer having to part with $50 for a card or stump up renewal fees coincides with the commencement of...

A study looking at the prevalence and nature of cannabis use in headache patients attending a Canadian tertiary headache clinic found a significant proportion were finding it helpful. But there were some concerning issues revealed.The researchers – a neurologist and headache specialist from Ontario, another from the Department of...

Australia's Little Green Pharma (ASX:LGP) has received Human Research Ethics Approval for a study to support its efforts towards an Australian Schedule 3 cannabidiol (CBD) product registration.LGP's Phase III efficacy and safety trial involves the company's LGP Classic CBD 50 cannabis medicine, which would target stress reduction and improved...

Findings of an Australian trial of cannabidiol (CBD) oil use for palliative care patients with advanced cancer aren't encouraging.The trial conducted by Mater Research and the University of Queensland investigated symptom relief among 144 patients from the greater Brisbane area. Some patients were given a self-selected dose of CBD...

Many people are interested in medical cannabis - and media coverage could be impacting clinical trial results suggests a new study.Researchers at Sweden's Karolinska Institutet's Department of Clinical Neuroscience analysed 20 published clinical studies in which cannabis has been compared with placebo for clinical pain treatment. They observed no...